Incidence of Pancreatic Malignancy and Thyroid Neoplasm in Type 2 Diabetes Mellitus Patients who Initiate Exenatide Compared to Other Antihyperglycemic Drugs - Phase 2 (Extended Accrual and Follow-Up)

First published 06/07/2016

Last updated 02/07/2024

EU PAS number:

EUPAS13956

Study

Finalised

Documents

Study protocol

Initial protocol

Redacted protocol BO15

English (746.88 KB - PDF)View document

Study results

D5550R00003 (EUPAS13956) Revised Final Report 17APR2018_AZ_Redacted

English (4.07 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs